Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Mir

Showing results (21-30 of 72) with videos related to

Pageof 8
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 8, 2011
Sorafenib-induced diarrhea and hypophosphatemia: mechanisms and therapeutic implicationsO Mir, R Coriat, P Boudou-Rouquette, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 4, 2008
Chemotherapy for breast cancer during pregnancy: is epirubicin safe?O Mir, P Berveiller, R Rouzier, et al.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|June 22, 2012
[Pregnancy after breast cancer: an update]A-L Margulies, P Berveiller, O Mir, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 26, 2012
Objective response to sorafenib in advanced clear-cell sarcomaO Mir, P Boudou-Rouquette, F Larousserie, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 6, 2009
Taxanes for breast cancer during pregnancy: a systematic reviewO Mir, P Berveiller, F Goffinet, et al.
Health Policy (Amsterdam, Netherlands)|January 1, 2023
The use of patient-reported outcome and experience measures for health policy purposes: A scoping review in oncologyE Minvielle, A Fierobe, A Fourcade, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 9, 2007
Emerging therapeutic options for breast cancer chemotherapy during pregnancyO Mir, P Berveiller, S Ropert, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 4, 2016
Percutaneous thermal ablation: A new treatment line in the multidisciplinary management of metastatic leiomyosarcoma?G Gravel, S Yevich, L Tselikas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 17, 2020
Sequential treatment with NOTCH inhibitor crenigacestat followed by pazopanib in soft tissue sarcoma patientsO Mir, S Watson, C Massard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 19, 2009
Relationship between GSTP1 Ile(105)Val polymorphism and docetaxel-induced peripheral neuropathy: clinical evidence of a role of oxidative stress in taxane toxicityO Mir, J Alexandre, A Tran, et al.
Pageof 8

Showing results (21-30 of 72) with videos related to

Sort By:
Pageof 8
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 8, 2011
Sorafenib-induced diarrhea and hypophosphatemia: mechanisms and therapeutic implicationsO Mir, R Coriat, P Boudou-Rouquette, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 4, 2008
Chemotherapy for breast cancer during pregnancy: is epirubicin safe?O Mir, P Berveiller, R Rouzier, et al.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|June 22, 2012
[Pregnancy after breast cancer: an update]A-L Margulies, P Berveiller, O Mir, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 26, 2012
Objective response to sorafenib in advanced clear-cell sarcomaO Mir, P Boudou-Rouquette, F Larousserie, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 6, 2009
Taxanes for breast cancer during pregnancy: a systematic reviewO Mir, P Berveiller, F Goffinet, et al.
Health Policy (Amsterdam, Netherlands)|January 1, 2023
The use of patient-reported outcome and experience measures for health policy purposes: A scoping review in oncologyE Minvielle, A Fierobe, A Fourcade, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 9, 2007
Emerging therapeutic options for breast cancer chemotherapy during pregnancyO Mir, P Berveiller, S Ropert, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 4, 2016
Percutaneous thermal ablation: A new treatment line in the multidisciplinary management of metastatic leiomyosarcoma?G Gravel, S Yevich, L Tselikas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 17, 2020
Sequential treatment with NOTCH inhibitor crenigacestat followed by pazopanib in soft tissue sarcoma patientsO Mir, S Watson, C Massard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 19, 2009
Relationship between GSTP1 Ile(105)Val polymorphism and docetaxel-induced peripheral neuropathy: clinical evidence of a role of oxidative stress in taxane toxicityO Mir, J Alexandre, A Tran, et al.
Pageof 8